Skip to main contentSkip to footer
finger pointing scan
Brighton & Sussex Medical School

Staff Profiles


BSMS > About BSMS > Contact us > Staff > Kathryn Monson

Kathryn Monson

Mrs Kathryn Monson (BSc, MSc)

Senior Trials Manager
E: K.Monson@sussex.ac.uk
T: +44 (0)1273 873034
Location: Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Room 11, University of Sussex, Brighton, BN1 9PX

Areas of expertise: Clinical trials; patient-reported outcomes; quality of life
Research areas: Breast cancer, head and neck cancer, colorectal cancer, radiotherapy

Biography

Kathryn Monson originally trained in medical physics and worked as a radiotherapy physicist at the Middlesex Hospital. She began her career in clinical trials at the Cancer Research Campaign Clinical Trials Centre, working as trial coordinator.  She continued to work in the same department (now CR UK & UCL Cancer Trials Centre), ultimately heading up a team running phase II and III trials in head & neck cancer, breast cancer and radiotherapy. During this time, Kathryn built up an interest in the long term side-effects of radiotherapy and their impact on patients’ quality of life. Since joining SHORE-C, Kathryn has continued to gain further experience on patient reported outcomes in head and neck, colorectal, ovarian and breast cancer.

Research

  • POSNOC – Positive Sentinel Node: adjuvant therapy alone versus adjuvant therapy plus clearance or axillary radiotherapy.  A randomised controlled trial of axillary treatment in women with early stage breast cancer who have metastases in one or two sentinel nodes
  • PulMiCC: A randomised trial of Pulmonary Metastasectomy in Colorectal Cancer
  • Targit-B: an international randomised controlled trial to compare targeted intra-operative radiotherapy boost after lumpectomy for breast cancer in women with a high risk of local recurrence

Selected publications

Implications of subcutaneous or intravenous delivery of traztuzumab; further insight from patient interviews in the PrefHer study. L Fallowfield, S Osborne, C Langridge, K Monson, J Kilkerr, V Jenkins.  The Breast, 2015 Apr; 24(2): 166-70

Operating to remove recurrent colorectal cancer: have we got it right? T Treasure, K Monson, F Fiorentino, C Russell. BMJ 2014 13 May; 348:g2085

The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer. T Treasure, K Monson, F Fiorentino, C Russell.  BMJ Open 2014; 4:e004385

Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study.  V Jenkins, S Catt, S Banerjee, C Gourley, A Montes, I Solis-Trapala, K Monson, L Fallowfield.  Br J Cancer. 2013 Jun 11; 108(11):2264-71

ARIX: a randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer.  R Simcock, L Fallowfield, K Monson, I Solis-Trapala, L Parlour, C Langridge, V Jenkins.  Ann Oncol. 2013 Mar; 24(3):776-83

Group recruitment sessions enhance patient understanding in a small multi-centre phase III clinical trial.  K Monson, L Parlour, R Simcock, L Fallowfield, V Jenkins.  Contemp Clin Trials. 2012 Mar; 33(2): 286-90